CoChat

Cohort Profile: The Doetinchem Cohort Study

Verschuren, W., Blokstra, A, Picavet, H., Smit, H. · 2008 · International Journal of Epidemiology
Cited by 211

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The origin of the Doetinchem Cohort Study lies within the Monitoring Project on Cardiovascular Disease Risk Factors (MP-CVDRF), which was aimed at providing prevalence estimates of cardiovascular disease risk factors, such as smoking, blood pressure and serum cholesterol levels. During 1987–91 each year an age- and sex-stratified random sample of men and women aged 20–59 years, was invited to participate. The MP-CVDRF was carried out in three towns in The Netherlands (Amsterdam in the west, Doetinchem in the east and Maastricht in the south), and from each of the three towns, about 12 000 men and women were examined. In the subsequent Monitoring Project on Chronic Disease Risk Factors (MORGEN-project), carried out from 1993–97, in Doetinchem only respondents from the MP-CVDRF were invited to participate, while in Amsterdam and Maastricht again random samples from the general population were examined. The protocol was extended, because the focus broadened from cardiovascular to other chronic diseases such as cancer, diabetes, musculoskeletal disorders and COPD. Due to extension of the protocol, with similar budget, not all 12 405 participants in the MP-CVDRF could be re-invited. Instead, a random sample of in total 7769 of the respondents at baseline was invited for re-examination. This random sample is considered the basis of the cohort (Figure 1). Flow chart of invitations and response leading to the study population of the Doetinchem Cohort Study The aim of the Doetinchem Cohort Study is to study the impact of (changes in) lifestyle factors and biological risk factors on aspects of health, such as the incidence of chronic diseases, physical and cognitive functioning and quality of life. During the course of the study, the scope has continuously broadened. At baseline, the focus was on determinants of cardiovascular diseases. Starting from the second examination of the cohort, the scope has extended to a broad spectrum of chronic diseases that have a substantial public health impact, such as diabetes, cancer, musculoskeletal disorders, asthma and COPD. During the fourth round the social aspects were assessed and in the fifth round that will start in 2008 the focus will be more on healthy ageing and the measures will also include bone density, osteoarthritis, osteoporosis and fractures, other chronic diseases than the big five (such as diseases of bowel, liver, thyroid gland), incontinence, muscle strength and tests for physical functioning. The study is thus aimed at a broad spectrum of hypotheses, with respect to both exposure and outcomes (Table 1). A biobank, with blood samples from each round of examination, enables us to study new hypotheses that come up during the study, when there is a biomarker that can be measured in the stored blood samples. Overview of themes measured in Doetinchem Cohort Study Overview of themes measured in Doetinchem Cohort Study The baseline measurements were carried out in 12 405 respondents from Doetinchem. This was a general population sample, drawn as an age (5-year age group) and gender stratified sample, from the municipal registers. Response rates at baseline were ∼62%. As described earlier, a sample of these respondents (N = 7769) are subsequently followed as a cohort. In Table 2, the baseline measurements of these 7769 men and women aged 20–59 years are described. Characteristics [mean (SD)] of participants of the Doetinchem Cohort Study at baseline (1987–1991) aSystolic ≥140 mmHg and/or diastolic ≥90 mmHg and/or anti-hypertensive medication. Characteristics [mean (SD)] of participants of the Doetinchem Cohort Study at baseline (1987–1991) aSystolic ≥140 mmHg and/or diastolic ≥90 mmHg and/or anti-hypertensive medication. The cohort is re-examined every 5 years. Only between the first and second round is 6 years, because a pilot year was necessary to test new elements of the study. The fourth round has been completed in 2007, and the fifth round has started in 2008, with funding from the Dutch Ministry of Public Health, Welfare and Sports. Respondents are also followed through linkage to several registers. All respondents are flagged in the national population register: if a respondent dies we are informed about the date of death. Regular linkage with the mortality register of Statistics Netherlands provides the cause of death of all respondents that have died. Incidence of cancer is based on linkage with the national cancer register (LKR), incidence of a broad range of diseases is based on linkage to the national hospital discharge register (LMR). From 1991 onwards, every prescribed medicine that has been collected at the pharmacist by a respondent is available through linkage with the pharmacy register (PHARMO). All these linkages are done for those respondents that have agreed on that in their informed consent (which is the case for over 95% of the respondents). Blood pressure was measured in each round, with the subject in sitting position. Systolic pressure was r

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dym292

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 211

Metadata

Authors
Verschuren, W., Blokstra, A., Picavet, H., & Smit, H.
Venue
International Journal of Epidemiology
Published
2008-01-31
Volume
37
Issue
6
Pages
1236-1241
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2168009606
Cited by
211
References
1
FWCI
11.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cohort Profile: The Doetinchem Cohort Study. https://app.cochat.ai/papers/10.1093/ije/dym292
The paper
Verschuren, W., Blokstra, A., Picavet, H., & Smit, H. (2008). Cohort Profile: The Doetinchem Cohort Study. International Journal of Epidemiology. https://doi.org/10.1093/ije/dym292

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.